Tech Company Financing Transactions
TippingPoint Biosciences Funding Round
BrightEdge and The Sontag Foundation participated in a Seed venture round for TippingPoint Biosciences. This VC investment round closed on 9/4/2024.
Transaction Overview
Company Name
Announced On
9/4/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development effrots.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
953 Indiana St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Email Address
Overview
TippingPoint Biosciences' mission is to treat diseases caused by dysfunctional genome chromatin packaging that are difficult to target using conventional approaches.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Hsieh
Chief Scientific Officer
Gary Li
Browse more venture capital transactions:
Prev: 9/4/2024: Baseload Capital venture capital transaction
Next: 9/4/2024: Root Signals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs